Large orders frequently appearing in the field of AI pharmaceuticals, scarce growth concept stocks.

In the field of AI pharmaceuticals, large orders are frequent, confirming the industry's high prosperity. In the A-share market, the concept theme related to AI pharmaceuticals is AI medical care, totaling 82 stocks. In terms of future growth, according to the consistent predictions of two or more institutions, 20 stocks have a net profit growth rate exceeding 20% in 2021, 2022, and 2027. These high-growth concept stocks are mainly concentrated in the medical and biological industries, with few stocks related to AI pharmaceuticals, some of which have AI-related information mentioned in research reports. In terms of stock price performance, the market's recognition of the listed concept stocks is relatively high, with an average increase of nearly 58% year-to-date, far exceeding the overall market level, with Yipinghong and Meidisixi both increasing by over 100%. Currently, the performance of listed concept stocks is mostly related to innovative drugs. With the fermentation of the AI pharmaceutical theme, related stocks may have new trends.